S. Latifyan

Type

Articles (9) Reviews (5)

Co-author

Date

Source

Keyword

Human beings (7) Patients (6) Patients (6) Immunotherapy (6) Immunotherapy (5) disease (4) Treatment (4) disease (4) research (3) oncology (3) gene (3) Selection (3) Year (3) Research (3) Oncology (3) Melanoma (3) Hope (3) Biochemical markers (3) Research (3) Use (3) therapy (2) standard (2) skin (2) rate (2) Cancer (2) Article (2) Inhibitors (2) Therapeutics (2) Theater (2) Skin (2)

Documents written by S. Latifyan (9) | is about S. Latifyan (0)

Cancer de l’endomètre : entre modernité et immunothérapie [Endometrial cancer in the crossroads of modernity and immunotherapy]
B. Giacomuzzi Moore et al. (May 17, 2023)
Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events.
A. Coukos et al.
Oncologie [2021 Oncology update]
M.L. Meyer et al. (Feb 2, 2022)
68Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis.
S. Boughdad et al.
Immunothérapie dans le cancer de la vessie : mise à jour 2021 [Immunotherapy for bladder cancer in 2021]
C. Cisarovsky et al. (May 19, 2021)
Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany.
J.M. Ressler et al.
Mélanome localement avancé et métastatique : nouveautés [Locally advanced and metastatic melanoma : novelties]
A. Huber et al. (May 27, 2020)
Oncologie [Advances in Oncology 2019]
A. Vernadou et al. (Jan 15, 2020)
Oncologie [Advances in Oncology 2019]
A. Vernadou et al. (Jan 15, 2020)